How much does Valganciclovir cost? The big price difference between domestic and foreign countries revealed

Valganciclovir, whose generic name is valganciclovir, is an antiviral drug designed to treat cytomegalovirus (CMV) infection, especially for patients after organ transplantation or with compromised immune function. This drug effectively inhibits the replication process of virusDNA, thereby achieving precise control of viral infection and significantly improving the patient's quality of life.

In the domestic market, Vancevi has been officially launched, but unfortunately, it has not yet been included in the medical insurance catalog, which means that patients need to bear all the drug costs. At present, the price of the domestically developed Vancevit (specification: 450mg*60 tablets) is quite high, generally around more than 10,000 yuan. The specific price will fluctuate depending on the region and hospital. In order to obtain the most accurate price information, it is recommended that patients go directly to their local hospital or regular pharmacy for consultation.

Compared with China, the price of Vancevir in overseas markets is more affordable, especially the original version of the drug in India and Turkey. These versions of the drug are priced at about three to four thousand yuan. Not only are they affordable, but their ingredients and efficacy are consistent with the domestic original drugs, which can fully meet the treatment needs of patients. Therefore, many patients choose to purchase the overseas version of Vancevir through legal channels to reduce their financial burden.

When purchasing Vancevit, patients must choose formal channels, such as domestic hospital pharmacies or international drug purchasing agencies, to ensure the legality and safety of the drug. At the same time, you must strictly follow the doctor's instructions when using drugs and avoid adjusting the dosage or usage on your own to prevent adverse reactions or affect the efficacy.

In addition, Vancevi may cause some side effects during use, such as nausea, vomiting, diarrhea, etc., and may also lead to abnormalities in blood indicators. Therefore, patients with low immunity need to monitor blood routine regularly so that treatment plans can be adjusted in a timely manner. Pregnant and breastfeeding women should consult a doctor for a risk assessment before use.

xa0

Reference materials

"Valganciclovir Instructions" https://www.drugs.com/pro/valganciclovir.html